{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T21:13:50Z","timestamp":1788642830390,"version":"build-2803163510"},"reference-count":64,"publisher":"Elsevier","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.irn.2025.04.025","type":"book-chapter","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T19:40:35Z","timestamp":1747424435000},"source":"Crossref","is-referenced-by-count":4,"title":["Congenital myasthenic syndromes"],"prefix":"10.1016","author":[{"given":"Sally","family":"Spendiff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanns","family":"Lochm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo A.","family":"Maselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/bs.irn.2025.04.025_bib1","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1002\/humu.22130","article-title":"Congenital myasthenic syndromes: Achievements and limitations of phenotype-guided gene-after-gene sequencing in diagnostic practice: A study of 680 patients","volume":"33","author":"Abicht","year":"2012","journal-title":"Human Mutation"},{"issue":"7","key":"10.1016\/bs.irn.2025.04.025_bib2","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1212\/WNL.53.7.1564","article-title":"A common mutation (epsilon1267delG) in congenital myasthenic patients of gypsy ethnic origin","volume":"53","author":"Abicht","year":"1999","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2025.04.025_bib3","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1055\/s-0038-1654706","article-title":"Clinical and genetic features of congenital myasthenic syndromes due to CHAT mutations: Case report and literature review","volume":"49","author":"Arican","year":"2018","journal-title":"Neuropediatrics"},{"issue":"6203","key":"10.1016\/bs.irn.2025.04.025_bib4","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1126\/science.1250744","article-title":"Neuromuscular disease. DOK7 gene therapy benefits mouse models of diseases characterized by defects in the neuromuscular junction","volume":"345","author":"Arimura","year":"2014","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.irn.2025.04.025_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/B978-0-323-90820-7.00013-6","article-title":"Congenital myasthenic syndromes","volume":"203","author":"Beeson","year":"2024","journal-title":"Handbook of Clinical Neurology"},{"issue":"Pt 9","key":"10.1016\/bs.irn.2025.04.025_bib6","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/brain\/awv185","article-title":"Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies","volume":"138","author":"Belaya","year":"2015","journal-title":"Brain: A Journal of Neurology"},{"issue":"19\u201320","key":"10.1016\/bs.irn.2025.04.025_bib7","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1089\/hum.2020.259","article-title":"The platform vector gene therapies project: Increasing the efficiency of adeno-associated virus gene therapy clinical trial startup","volume":"31","author":"Brooks","year":"2020","journal-title":"Human Gene Therapy"},{"issue":"6","key":"10.1016\/bs.irn.2025.04.025_bib8","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1212\/01.WNL.0000085865.55513.AE","article-title":"Rapsyn mutations in hereditary myasthenia: Distinct early- and late-onset phenotypes","volume":"61","author":"Burke","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2025.04.025_bib9","article-title":"Dose escalation pre-clinical trial of novel DOK7-AAV in mouse model of DOK7 congenital myasthenia","author":"Cossins","year":"2024","journal-title":"bioRxiv: The Preprint Server for Biology"},{"issue":"4","key":"10.1016\/bs.irn.2025.04.025_bib10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.nmd.2017.11.013","article-title":"Congenital myasthenic syndromes in Turkey: Clinical clues and prognosis with long term follow-up","volume":"28","author":"Durmus","year":"2018","journal-title":"Neuromuscular Disorders: NMD"},{"issue":"10","key":"10.1016\/bs.irn.2025.04.025_bib11","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1007\/s00415-009-5190-7","article-title":"AChR deficiency due to epsilon-subunit mutations: Two common mutations in the Netherlands","volume":"256","author":"Faber","year":"2009","journal-title":"Journal of Neurology"},{"issue":"18","key":"10.1016\/bs.irn.2025.04.025_bib12","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus Sham control in infantile-onset spinal muscular atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.025_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000381252","article-title":"Factors associated with adverse events during tracheal intubation in the NICU","volume":"108","author":"Foglia","year":"2015","journal-title":"Neonatology"},{"key":"10.1016\/bs.irn.2025.04.025_bib14","doi-asserted-by":"crossref","unstructured":"Franklin. (n.d.) https:\/\/franklin.genoox.com\/clinical-db\/home. (Accessed 29 November 2024).","DOI":"10.1016\/j.jocn.2023.12.018"},{"issue":"4","key":"10.1016\/bs.irn.2025.04.025_bib15","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/mus.24687","article-title":"A severe congenital myasthenic syndrome with \u2018Dropped Head\u2019 caused by novel MUSK mutations","volume":"52","author":"Giarrana","year":"2015","journal-title":"Muscle & Nerve"},{"issue":"4","key":"10.1016\/bs.irn.2025.04.025_bib16","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pediatrneurol.2012.02.003","article-title":"Recurrent COLQ mutation in congenital myasthenic syndrome","volume":"46","author":"Guven","year":"2012","journal-title":"Pediatric Neurology"},{"issue":"7","key":"10.1016\/bs.irn.2025.04.025_bib17","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/ajmg.a.61186","article-title":"SLC18A3 Variants lead to fetal akinesia deformation sequence early in pregnancy","volume":"179","author":"Hakonen","year":"2019","journal-title":"American Journal of Medical Genetics. Part A"},{"issue":"October","key":"10.1016\/bs.irn.2025.04.025_bib18","article-title":"512P Investigating muscle specific kinase agonist antibody treatment for agrn and ColQ congenital myasthenic syndromes","volume":"43","author":"Ho","year":"2024","journal-title":"Neuromuscular Disorders"},{"issue":"September","key":"10.1016\/bs.irn.2025.04.025_bib19","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.omtn.2023.07.036","article-title":"Long-term muscle-specific overexpression of DOK7 in mice using AAV9-tMCK-DOK7","volume":"33","author":"Huang","year":"2023","journal-title":"Molecular Therapy. Nucleic Acids"},{"issue":"9","key":"10.1016\/bs.irn.2025.04.025_bib20","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.ijporl.2010.05.022","article-title":"Congenital stridor with feeding difficulty as a presenting symptom of Dok7 congenital myasthenic syndrome","volume":"74","author":"Jephson","year":"2010","journal-title":"International Journal of Pediatric Otorhinolaryngology"},{"issue":"19","key":"10.1016\/bs.irn.2025.04.025_bib21","doi-asserted-by":"crossref","first-page":"e1770","DOI":"10.1212\/WNL.0000000000006478","article-title":"Congenital myasthenic syndromes in adult neurology clinic: A long road to diagnosis and therapy","volume":"91","author":"Kao","year":"2018","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/bs.irn.2025.04.025_bib22","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1001\/archotol.128.11.1249","article-title":"Indications for tracheotomy in the pediatric intensive care unit population: A pilot study","volume":"128","author":"Lee","year":"2002","journal-title":"Archives of Otolaryngology--Head & Neck Surgery"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2025.04.025_bib23","article-title":"A novel mutation in the TPR6 domain of the RAPSN gene associated with congenital myasthenic syndrome","volume":"316","author":"Leshinsky-Silver","year":"2012","journal-title":"Journal of the Neurological Sciences"},{"issue":"3\u20134","key":"10.1016\/bs.irn.2025.04.025_bib24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/hum.2023.173","article-title":"Adeno-associated virus type 9-mediated gene therapy of choline acetyltransferase-deficient mice","volume":"35","author":"Lin","year":"2024","journal-title":"Human Gene Therapy"},{"issue":"3","key":"10.1016\/bs.irn.2025.04.025_bib25","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10072-018-3682-x","article-title":"Italian recommendations for diagnosis and management of congenital myasthenic syndromes","volume":"40","author":"Maggi","year":"2019","journal-title":"Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"},{"issue":"1S","key":"10.1016\/bs.irn.2025.04.025_bib26","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/j.otsr.2017.04.019","article-title":"Neuromuscular diseases: Diagnosis and management","volume":"104","author":"Mary","year":"2018","journal-title":"Orthopaedics & Traumatology, Surgery & Research: OTSR"},{"issue":"5","key":"10.1016\/bs.irn.2025.04.025_bib27","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1399-0004.2010.01602.x","article-title":"Congenital myasthenic syndrome associated with epidermolysis bullosa caused by homozygous mutations in PLEC1 and CHRNE","volume":"80","author":"Maselli","year":"2011","journal-title":"Clinical Genetics"},{"issue":"14","key":"10.1016\/bs.irn.2025.04.025_bib28","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1093\/hmg\/ddz059","article-title":"Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome","volume":"28","author":"McMacken","year":"2019","journal-title":"Human Molecular Genetics"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.025_bib29","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s00415-017-8689-3","article-title":"Congenital myasthenic syndrome with episodic apnoea: Clinical, neurophysiological and genetic features in the long-term follow-up of 19 patients","volume":"265","author":"McMacken","year":"2018","journal-title":"Journal of Neurology"},{"issue":"Pt 3","key":"10.1016\/bs.irn.2025.04.025_bib30","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/brain\/awm325","article-title":"Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes","volume":"131","author":"Mihaylova","year":"2008","journal-title":"Brain: A Journal of Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.025_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/ped.15115","article-title":"Tulobuterol is a potential therapeutic drug in congenital myasthenic syndrome","volume":"64","author":"Miyana","year":"2022","journal-title":"Pediatrics International: Official Journal of the Japan Pediatric Society"},{"issue":"11","key":"10.1016\/bs.irn.2025.04.025_bib32","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1212\/01.WNL.0000072262.14931.80","article-title":"Rapsyn N88K Is a frequent cause of congenital myasthenic syndromes in European patients","volume":"60","author":"M\u00fcller","year":"2003","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/bs.irn.2025.04.025_bib33","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.nmd.2017.08.003","article-title":"Molecular characterization of congenital myasthenic syndromes in Spain","volume":"27","author":"Natera-de Benito","year":"2017","journal-title":"Neuromuscular Disorders: NMD"},{"key":"10.1016\/bs.irn.2025.04.025_bib34","unstructured":"National Center for Biotechnology Information. (n.d.). https:\/\/www.ncbi.nlm.nih.gov\/. (Accessed 29 November 2024)."},{"issue":"1","key":"10.1016\/bs.irn.2025.04.025_bib35","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/nyas.13520","article-title":"Clinical and research strategies for limb-girdle congenital myasthenic syndromes: Limb-girdle congenital myasthenic syndromes","volume":"1412","author":"O\u2019Connor","year":"2018","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"10","key":"10.1016\/bs.irn.2025.04.025_bib36","doi-asserted-by":"crossref","first-page":"8505","DOI":"10.3390\/ijms24108505","article-title":"Mitochondrial mutations can alter neuromuscular transmission in congenital myasthenic syndrome and mitochondrial disease","volume":"24","author":"O\u2019Connor","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"10.1016\/bs.irn.2025.04.025_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2024.e00318","article-title":"Calcitriol ameliorates motor deficits and prolongs survival of chrne-deficient mouse, a model for congenital myasthenic syndrome, by inducing Rspo2","volume":"21","author":"Ohkawara","year":"2024","journal-title":"Neurotherapeutics: The Journal of the American Society for Experimental NeuroTherapeutics"},{"issue":"4","key":"10.1016\/bs.irn.2025.04.025_bib38","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.3390\/ijms24043730","article-title":"Clinical and pathologic features of congenital myasthenic syndromes caused by 35 genes-A comprehensive review","volume":"24","author":"Ohno","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.irn.2025.04.025_bib39","unstructured":"OMIM. (n.d.). https:\/\/www.omim.org\/. (Accessed 29 November 2024)."},{"issue":"7867","key":"10.1016\/bs.irn.2025.04.025_bib40","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41586-021-03672-3","article-title":"Mechanism of disease and therapeutic rescue of Dok7 congenital myasthenia","volume":"595","author":"Oury","year":"2021","journal-title":"Nature"},{"issue":"3","key":"10.1016\/bs.irn.2025.04.025_bib41","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000200155","article-title":"Homozygosity of a founder variant c.1508dupC in DOK7 causes congenital myasthenia with variable severity","volume":"10","author":"Palmio","year":"2024","journal-title":"Neurology. Genetics"},{"issue":"6","key":"10.1016\/bs.irn.2025.04.025_bib42","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/archdischild-2013-304788","article-title":"How common is childhood myasthenia? The UK incidence and prevalence of autoimmune and congenital myasthenia","volume":"99","author":"Parr","year":"2014","journal-title":"Archives of Disease in Childhood"},{"issue":"10","key":"10.1016\/bs.irn.2025.04.025_bib43","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.nmd.2020.08.362","article-title":"Congenital myasthenic syndromes in the thai population: Clinical findings and novel mutations","volume":"30","author":"Pattrakornkul","year":"2020","journal-title":"Neuromuscular Disorders: NMD"},{"key":"10.1016\/bs.irn.2025.04.025_bib44","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.3389\/fneur.2019.01300","article-title":"Congenital vocal cord paralysis and late-onset limb-girdle weakness in MuSK-congenital myasthenic syndrome","volume":"10","author":"Pinto","year":"2019","journal-title":"Frontiers in Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2025.04.025_bib45","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10048-021-00658-1","article-title":"A founder mutation in the GMPPB gene [c.1000G\u00a0>\u00a0A (p.Asp334Asn)] causes a mild form of limb-girdle muscular dystrophy\/congenital myasthenic syndrome (LGMD\/CMS) in South Indian patients","volume":"22","author":"Polavarapu","year":"2021","journal-title":"Neurogenetics"},{"issue":"June","key":"10.1016\/bs.irn.2025.04.025_bib46","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.nmd.2024.03.011","article-title":"Partial loss of desmin expression due to a leaky splice site variant in the human DES gene is associated with neuromuscular transmission defects","volume":"39","author":"Polavarapu","year":"2024","journal-title":"Neuromuscular Disorders: NMD"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.025_bib47","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/brain\/awad315","article-title":"Clinical and genetic characterisation of a large Indian congenital myasthenic syndrome cohort","volume":"147","author":"Polavarapu","year":"2024","journal-title":"Brain: A Journal of Neurology"},{"issue":"6","key":"10.1016\/bs.irn.2025.04.025_bib48","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad299","article-title":"Congenital myasthenic syndromes: A retrospective natural history study of respiratory outcomes in a single centre","volume":"5","author":"Poulos","year":"2023","journal-title":"Brain Communications"},{"issue":"5","key":"10.1016\/bs.irn.2025.04.025_bib49","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3233\/JND-221646","article-title":"Presynaptic congenital myasthenic syndromes: Understanding clinical phenotypes through in vivo models","volume":"10","author":"Pugliese","year":"2023","journal-title":"Journal of Neuromuscular Diseases"},{"issue":"10","key":"10.1016\/bs.irn.2025.04.025_bib50","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.nmd.2021.07.400","article-title":"Congenital myasthenic syndromes: Where do we go from here?","volume":"31","author":"Ramdas","year":"2021","journal-title":"Neuromuscular Disorders: NMD"},{"issue":"24","key":"10.1016\/bs.irn.2025.04.025_bib51","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1212\/01.wnl.0000336921.51639.0b","article-title":"The CHRNE 1293insG founder mutation is a frequent cause of congenital myasthenia in North Africa","volume":"71","author":"Richard","year":"2008","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2025.04.025_bib52","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.nmd.2022.12.011","article-title":"A novel phenotype of AChR-deficiency syndrome with predominant facial and distal weakness resulting from the inclusion of an evolutionary alternatively-spliced exon in CHRNA1","volume":"33","author":"Rodr\u00edguez Cruz","year":"2023","journal-title":"Neuromuscular Disorders: NMD"},{"key":"10.1016\/bs.irn.2025.04.025_bib53","unstructured":"SIMPATHIC \u2013 Drug Repurposing in Rare Diseases. (n.d.).\u00a0https:\/\/simpathic.eu\/. (Accessed 31 October 2024)."},{"key":"10.1016\/bs.irn.2025.04.025_bib54","series-title":"StatPearls","article-title":"Pediatric tracheostomy","author":"Singh","year":"2024"},{"issue":"9","key":"10.1016\/bs.irn.2025.04.025_bib55","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.nmd.2022.12.006","article-title":"260th ENMC international workshop: Congenital myasthenic syndromes 11-13 March 2022, Hoofddorp, The Netherlands","volume":"33","author":"Spendiff","year":"2023","journal-title":"Neuromuscular Disorders: NMD"},{"issue":"7","key":"10.1016\/bs.irn.2025.04.025_bib56","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.nmd.2010.05.007","article-title":"DOK7 mutations presenting as a proximal myopathy in French canadians","volume":"20","author":"Srour","year":"2010","journal-title":"Neuromuscular Disorders: NMD"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.025_bib57","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1042\/ETLS20180100","article-title":"Targeted therapies for congenital myasthenic syndromes: Systematic review and steps towards a treatabolome","volume":"3","author":"Thompson","year":"2019","journal-title":"Emerging Topics in Life Sciences"},{"issue":"May","key":"10.1016\/bs.irn.2025.04.025_bib58","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejpn.2020.02.002","article-title":"Prevalence and genetic subtypes of congenital myasthenic syndromes in the pediatric population of slovenia","volume":"26","author":"Troha Gergeli","year":"2020","journal-title":"European Journal of Paediatric Neurology: EJPN: Official Journal of the European Paediatric Neurology Society"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.025_bib59","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/s41467-023-36277-7","article-title":"TEFM variants impair mitochondrial transcription causing childhood-onset neurological disease","volume":"14","author":"Van Haute","year":"2023","journal-title":"Nature Communications"},{"issue":"765","key":"10.1016\/bs.irn.2025.04.025_bib60","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ado7189","article-title":"ARGX-119 Is an agonist antibody for human MuSK that reverses disease relapse in a mouse model of congenital myasthenic syndrome","volume":"16","author":"Vanhauwaert","year":"2024","journal-title":"Science Translational Medicine"},{"issue":"5","key":"10.1016\/bs.irn.2025.04.025_bib61","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/jmg.2008.065425","article-title":"Germline mutation in DOK7 associated with fetal Akinesia deformation sequence","volume":"46","author":"Vogt","year":"2009","journal-title":"Journal of Medical Genetics"},{"issue":"11","key":"10.1016\/bs.irn.2025.04.025_bib62","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1002\/lary.25972","article-title":"Two-year mortality, complications, and healthcare use in children with medicaid following tracheostomy","volume":"126","author":"Watters","year":"2016","journal-title":"The Laryngoscope"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.025_bib63","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1038\/s41467-020-19230-w","article-title":"Identification of a myotropic AAV by massively parallel in vivo evaluation of barcoded capsid variants","volume":"11","author":"Weinmann","year":"2020","journal-title":"Nature Communications"},{"issue":"3","key":"10.1016\/bs.irn.2025.04.025_bib64","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/jmedgenet-2014-102730","article-title":"MuSK: A new target for lethal fetal akinesia deformation sequence (FADS)","volume":"52","author":"Wilbe","year":"2015","journal-title":"Journal of Medical Genetics"}],"container-title":["International Review of Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774225000406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774225000406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T02:01:04Z","timestamp":1747965664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774225000406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":64,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2025.04.025","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}